Insiders Takeda Pharmaceutical Company Limited London S.E.

Equities

0RN3

JP3463000004

Market Closed - London S.E. Other stock markets 04:58:26 26/03/2019 pm IST			5-day change	1st Jan Change
37.59 ^EUR	+6.79%		-.--%	-.--%

25/06	US CDC alerts healthcare providers of increase in dengue cases	RE
25/06	Takeda's Cancer Drug Gets European Commission Approval	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Takeda Pharmaceutical Company Limited Announces Demise of its Board Member, Olivier Bohuon	09/05	CI
Takeda Pharmaceutical Names Milano Furuta as Chief Financial Officer	01/02	MT
Antisense Therapeutics Appoints CEO/Managing Director	07/23/07	MT
Takeda Pharmaceutical Company Limited Announces Board Changes	28/23/28	CI
Takeda Pharmaceutical Company Limited Announces Masato Iwasaki, Representative Director Expresses His Intention to Retire on June 28Th	30/23/30	CI
Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO	29/23/29	AN
Takeda Pharmaceutical Company Limited Announces New Assignments of Directors	29/22/29	CI
Takeda Pharmaceutical Company Limited Announces Board Appointments	29/22/29	CI
OncoSec Medical Names Robert Arch CEO; Shares Rise Early	30/22/30	MT
Takeda Pharmaceutical Company Limited Announces Executive Changes	01/22/01	CI
Former Takeda vaccine chief to lead new COVID antiviral venture Aerium	22/22/22	RE
Takeda Announces Management Changes	03/22/03	CI
Takeda Announces New Assignments of Directors	29/21/29	CI
Takeda Pharmaceutical Company Limited Announces Retirement of Yasuhiko Yamanaka as Director and Member of Audit and Supervisory Committee	28/21/28	CI
Takeda Announces Directorate Changes	31/21/31	CI
Takeda Pharmaceutical Company Limited Announces Executive Changes	15/21/15	CI
Nabriva Therapeutics : Names Daniel Dolan CFO	26/21/26	MT
Takeda Pharmaceutical : Rute Fernandes Appointed General Manager of Takeda Canada	08/21/08	AQ
Takeda Pharmaceutical : Named Global Top Employer for Fourth Consecutive Year	25/21/25	PU
Takeda Appoints Ebru Yavuz as CEO of Newly Formed Ukraine and CIS Cluster	09/20/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Takeda Pharmaceutical Company Limited London S.E.

Equities

0RN3

JP3463000004

Insiders

Filters